In Brief: Helionetics/Laser Photonics
This article was originally published in The Gray Sheet
Executive SummaryHelionetics/Laser Photonics: U.S. Bankruptcy Court for the Middle District of Florida confirms a reorganization plan for diode and gas laser system manufacturer Laser Photonics under which Helionetics acquires 75% of common stock in Laser Photonics in exchange for the transfer to Laser Photonics of its 75% stake in excimer laser firm AccuLase and $1 mil. in cash. Helionetics says that Laser Photonics, which reported a 1994 loss of $600,000 on sales of $5.3 mil., will offer "laser manufacturing capabilities" that could accelerate AccuLase's commercialization of its transmyocardial revascularization and laser angioplasty products. In addition, Laser Photonics has developed a "relatively small excimer laser prototype" that could be used in "emerging technologies, such as photorefractive keratectomy," Helionetics says...
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.